Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 2004

View Archived Issues

Desmoteplase shows potential utility for stroke

BioMarin highlights 2003 developments

Roche highlights significant events in 2003

Aastrom Biosciences reports active and productive 1H 2004

Nuvelo: Q4 and year-end 2003 highlights

Prous Science announces new multimedia iNOS homodimerization animation on the LifeSci Channel

Preliminary phase III data suggests therapeutic benefits for Dacogen(TM) in MDS

A recombinant vaccine reduces recurrence of genital herpes

Schering-Plough presents new NK1 antagonists in a recent patent

Two series of MCH1 antagonists and their use reported by Synaptic researchers

Novel PPARdelta agonists under study at Bayer

Bayer claims PDE10A inhibitors for Parkinson's disease, schizophrenia and cancer

Roche presents novel NPY antagonists with potential in obesity and other disorders

Dual NK1 antagonists/5-HT reuptake inhibitors identified at GSK

New cysteine protease inhibitors prepared and tested at Georgia Tech Research

ImmunoGen describes anti-Muc1 and Muc16 antibodies and their therapeutic use

KRH-2731: A novel chemokine antagonist for HIV-1 therapy

Combination of chemokine antagonists for HIV-1 therapy

EGFR pharmDx kit receives FDA approval

tgAAC-09 enters new clinical trial for prevention of AIDS

Infectio Diagnostic and bioMerieux enter partnership

FP-0011 enters phase I trial for ALS

Phase IIb trial to assess TP-10 in women undergoing cardiac surgery with CBP

PEG-Intron Redipen gets U.S. launch

Intercell and Aventis to develop bacterial vaccines

FDA guidance regarding Altropane SPA submission

Dow to produce NLC-001 in plant-based system

PMA submission for PowerLink accepted for filing by FDA

K5-N,OS(H), a potential topical microbicide for HIV transmission prevention

Clinically meaningful antiviral effects of TNX-355 in HIV-infected patients

Potential use of CpG-7909 as a vaccine adjunct in HIV-infected patients

An in vitro study suggests an improved safety profile for BAY-50-4798 in HIV patients